Patents by Inventor Juergen STEFFGEN

Juergen STEFFGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20230265203
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: October 7, 2022
    Publication date: August 24, 2023
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry Nabozny, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20190177420
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: July 18, 2018
    Publication date: June 13, 2019
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald Brodeur, Thomas B. Freeman, Gerald Henery Nabozny, Meera Ramanujam, Paul Scholl, Juergen Steffgen
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20170058038
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 2, 2017
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry NABOZNY, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN